drugset / Trial / NCT02156739
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
Active not recruiting
100 enrolled
M.D. Anderson Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate disodium and gadobutrol, may help doctors to see MRI images more clearly.
Timeline
- Start
- 2014-10-13
- Primary completion
- 2028-06-01
- Completion
- 2028-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadobutrol | Diagnostic / imaging agent | — | Intravenous |
| Subject | Gadoxetate Disodium | Diagnostic / imaging agent | — | Intravenous |